Penumbra Inc
Veridion Score
Composite trend over time
Why is PEN moving today?
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for PEN.
PEN insider activity
Penumbra Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$33.4M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | 2026-04-02 | Grewal Harpreet | Insider | sell | $328.22 | 100 | 8,719 | $33K | SEC Form 4 |
| 2026-03-17 | 2026-03-15 | Narayan Shruthi | Insider | sell | $336.18 | 117 | 30,755 | $39K | SEC Form 4 |
| 2026-03-17 | 2026-03-15 | Shiu Lambert | Insider | sell | $336.18 | 150 | 39,323 | $50K | SEC Form 4 |
| 2026-03-17 | 2026-03-15 | Yuen Maggie | Insider | sell | $336.18 | 186 | 18,167 | $63K | SEC Form 4 |
| 2026-03-17 | 2026-03-15 | Roberts Johanna | Insider | sell | $336.18 | 186 | 67,298 | $63K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 107 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moPEN contract awards, year to date.
Public federal awards linked to this ticker.
PEN lobbying filings, year to date.
Registered lobbying filings matched to Penumbra Inc.